A 2001 study published in the journal Obesity Research demonstrated that AOD 9604 stimulated lipolysis and inhibited lipogenesis in laboratory settings
Structure-activity studies of GHS-R1a pentapeptide agonists
The weight reduction associated with GLP-1 agonists could help mitigate the weight gain associated with basal insulin
For Foundayo specifically, Lilly lists common side effects including nausea, constipation, diarrhea, vomiting, indigestion, abdominal pain, headache, bloating, fatigue, belching, heartburn, gas, and hair loss
Phase 3 (Weeks 3-8) : Both peptides support final repair, reducing scar formation and strengthening repaired tissue
This may be further pronounced in patients with diabetes with compromised gastrointestinal function due to autonomic neuropathy